SEC Company Response from AIM ImmunoTech Inc. (AIM) (CIK 0000946644) (AIM) — Sep 24, 2019
AIM ImmunoTech Inc. (AIM) (CIK 0000946644)
Date: Sept. 24, 2019 · CIK: 0000946644 · Accession: 0001493152-19-014477
AI Filing Summary & Sentiment
File numbers found in text: 333-233657
Show Raw Text
CORRESP
1
filename1.htm
A.G.P./Alliance
Global Partners
590
Madison Avenue
New
York, New York 10022
September
23, 2019
VIA
EDGAR
U.S.
Securities and Exchange Commission
100
F St., NE
Washington,
D.C. 20549
RE:
AIM
ImmunoTech Inc. (the “Company”)
File
No. 333-233657
Registration
Statement on Form S-1
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933,
as amended, A.G.P./Alliance Global Partners, as representative of the underwriters, hereby joins the request of the Company that
the effective date of the above-referenced Registration Statement be accelerated so that it will become effective at 5:30 p.m.
Eastern Time on September 24, 2019, or as soon thereafter as practicable.
Pursuant
to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably
anticipated to be invited to participate in the distribution of the securities, as many copies of the proposed form of preliminary
prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The
undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed
by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange
Act of 1934, as amended, in connection with the above-referenced issue.
Very truly yours,
A.G.P./Alliance Global Partners
By:
Thomas
J. Higgins
/s/
Thomas J. Higgins
Name:
Thomas
J. Higgins
Title:
Managing
Director